Merrimack Pharmaceuticals Stock Price on January 5, 2018
MACK Stock | USD 14.73 0.01 0.07% |
Below is the normalized historical share price chart for Merrimack Pharmaceuticals extending back to March 29, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Merrimack Pharmaceuticals stands at 14.73, as last reported on the 23rd of April, with the highest price reaching 14.78 and the lowest price hitting 14.71 during the day.
If you're considering investing in Merrimack Stock, it is important to understand the factors that can impact its price. We consider Merrimack Pharmaceuticals not too volatile. Merrimack Pharmaceuticals has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Merrimack Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Merrimack Pharmaceuticals' Risk Adjusted Performance of 0.0974, mean deviation of 0.5855, and Downside Deviation of 0.6897 to check out if the risk estimate we provide is consistent with the expected return of 0.17%.
At this time, Merrimack Pharmaceuticals' Total Stockholder Equity is quite stable compared to the past year. Common Stock Total Equity is expected to rise to about 1.8 M this year, although the value of Other Stockholder Equity will most likely fall to about 507.8 M. . At this time, Merrimack Pharmaceuticals' Price Book Value Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 6.84 this year, although the value of Price To Operating Cash Flows Ratio is projected to rise to (119.69). Merrimack Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of March 2012 | 200 Day MA 13.0752 | 50 Day MA 14.6818 | Beta 1.426 |
Merrimack |
Sharpe Ratio = 0.1449
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | MACK | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.2 actual daily | 10 90% of assets are more volatile |
Expected Return
0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average Merrimack Pharmaceuticals is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merrimack Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 11.3831 | Book Value 1.306 | Enterprise Value 194.8 M | Enterprise Value Ebitda (89.40) | Shares Float 9.4 M |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Merrimack Pharmaceuticals Stock history
Merrimack Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Merrimack is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Merrimack Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Merrimack Pharmaceuticals stock prices may prove useful in developing a viable investing in Merrimack Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 14.3 M | 10.9 M | |
Net Loss | -1.8 M | -1.9 M |
Merrimack Pharmaceuticals Quarterly Net Working Capital |
|
Merrimack Pharmaceuticals Stock Technical Analysis
Merrimack Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Merrimack Pharmaceuticals Period Price Range
Merrimack Pharmaceuticals April 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Merrimack Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Merrimack Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Merrimack Pharmaceuticals stock market strength indicators, traders can identify Merrimack Pharmaceuticals entry and exit signals to maximize returns
Merrimack Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Merrimack Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Merrimack Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Merrimack to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0974 | |||
Jensen Alpha | 0.2082 | |||
Total Risk Alpha | 0.0157 | |||
Sortino Ratio | 0.1299 | |||
Treynor Ratio | (0.34) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merrimack Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Merrimack Stock analysis
When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.08) | Return On Assets (0.07) | Return On Equity (0.06) |
The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.